Document
PGR2023-00043, No. 2007 Exhibit - Intl Pub No WO 2010135703A2 by Ahmad et al (P.T.A.B. Nov. 30, 2023)
Cite Document
PGR2023-00043, No. 2007 Exhibit - Intl Pub No WO 2010135703A2 by Ahmad et al (P.T.A.B. Nov. 30, 2023)
+ More Snippets
Document
PGR2023-00043, No. 2002 Exhibit - Elkins et al, Characterization of the isomeric configuration (P.T.A.B. Nov. 30, 2023)
Cite Document
PGR2023-00043, No. 2002 Exhibit - Elkins et al, Characterization of the isomeric configuration (P.T.A.B. Nov. 30, 2023)
+ More Snippets
Document
PGR2023-00043, No. 2019 Exhibit - Susan M Krumplitsch Declaration in Support of Motion for Pro Hac Vice (P.T.A.B. Nov. 30, 2023)
Cite Document
PGR2023-00043, No. 2019 Exhibit - Susan M Krumplitsch Declaration in Support of Motion for Pro Hac Vice (P.T.A.B. Nov. 30, 2023)
+ More Snippets
Document
PGR2023-00043, No. 2006 Exhibit - Excerpt of ’151 Patent File History FOA and NOA “’985 File History 3” (P.T.A.B. Nov. 30, 2023)
Cite Document
PGR2023-00043, No. 2006 Exhibit - Excerpt of ’151 Patent File History FOA and NOA “’985 File History 3” (P.T.A.B. Nov. 30, 2023)
+ More Snippets
Document
PGR2023-00043, No. 2016 Exhibit - Buchanan et al, “Solubilization and Dissolution of Tamoxifen Hydroxybutenyl Cyclodextrin Complexes,” J Pharm Sciences, 95102246 2255 2006 “Buchanan” ...
Cite Document
PGR2023-00043, No. 2016 Exhibit - Buchanan et al, “Solubilization and Dissolution of Tamoxifen Hydroxybutenyl Cyclodextrin Complexes,” J Pharm Sciences, 95102246 2255 2006 “Buchanan” (P.T.A.B. Nov. 30
+ More Snippets
Document
PGR2023-00043, No. 2004 Exhibit - Excerpt of ’151 Patent File History IDS Filings, Receipts, List Considered (P.T.A.B. Nov. 30, 2023)
Cite Document
PGR2023-00043, No. 2004 Exhibit - Excerpt of ’151 Patent File History IDS Filings, Receipts, List Considered (P.T.A.B. Nov. 30, 2023)
+ More Snippets
Document
PGR2023-00043, No. 2012 Exhibit - International Counsel for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (P.T.A.B. Nov. 30, 2023)
Cite Document
PGR2023-00043, No. 2012 Exhibit - International Counsel for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (P.T.A.B. Nov. 30, 2023)
+ More Snippets
Document
PGR2023-00043, No. 2011 Exhibit - Ali et al, “Endoxifen is a new potent inhibitor of PKC A potential therapeutic agent (P.T.A.B. Nov. 30, 2023)
Cite Document
PGR2023-00043, No. 2011 Exhibit - Ali et al, “Endoxifen is a new potent inhibitor of PKC A potential therapeutic agent (P.T.A.B. Nov. 30, 2023)
+ More Snippets
Document
PGR2023-00043, No. 2014 Exhibit - Center for Drug Evaluation and Research, FDA Guidance Document, “Development of New Stereoisomeric Drugs,” (P.T.A.B. Nov. 30, 2023)
Cite Document
PGR2023-00043, No. 2014 Exhibit - Center for Drug Evaluation and Research, FDA Guidance Document, “Development of New Stereoisomeric Drugs,” (P.T.A.B. Nov. 30, 2023)
+ More Snippets
Document
PGR2023-00043, No. 2018 Exhibit - Jacques et al, Enantiomers, Racemates, and Resolutions 1981 “Jacques” (P.T.A.B. Nov. 30, 2023)
Cite Document
PGR2023-00043, No. 2018 Exhibit - Jacques et al, Enantiomers, Racemates, and Resolutions 1981 “Jacques” (P.T.A.B. Nov. 30, 2023)
+ More Snippets
Document
PGR2023-00043, No. 2005 Exhibit - Excerpt of ’151 Patent File History Liu “’985 File History 2” (P.T.A.B. Nov. 30, 2023)
Cite Document
PGR2023-00043, No. 2005 Exhibit - Excerpt of ’151 Patent File History Liu “’985 File History 2” (P.T.A.B. Nov. 30, 2023)
+ More Snippets
Document
PGR2023-00043, No. 2009 Exhibit - Intl Pub No WO 2009120999A2 by Kushner et al (P.T.A.B. Nov. 30, 2023)
Cite Document
PGR2023-00043, No. 2009 Exhibit - Intl Pub No WO 2009120999A2 by Kushner et al (P.T.A.B. Nov. 30, 2023)
+ More Snippets
Document
PGR2023-00043, No. 2015 Exhibit - Lv et al, “Synthesis of mixed E,Z , E , and Z norendoxifen with dual aromatase inhibitory and estrogen receptor modulatory activities,” (P.T.A.B. Nov. 30, 2023...
Cite Document
PGR2023-00043, No. 2015 Exhibit - Lv et al, “Synthesis of mixed E,Z , E , and Z norendoxifen with dual aromatase inhibitory and estrogen receptor modulatory activities,” (P.T.A.B. Nov. 30, 2023)
+ More Snippets
Document
PGR2023-00043, No. 2017 Exhibit - Gupta et al, “Salts of Therapeutic Agents Chemical, Physicochemical, and Biological Considerations,” Molecules, 231719 2018 “Gupta” (P.T.A.B. Nov. 30, 20...
Cite Document
PGR2023-00043, No. 2017 Exhibit - Gupta et al, “Salts of Therapeutic Agents Chemical, Physicochemical, and Biological Considerations,” Molecules, 231719 2018 “Gupta” (P.T.A.B. Nov. 30, 2023)
+ More Snippets
Document
PGR2023-00043, No. 2001 Exhibit - Expert Declaration of Stephen Graham Davies, D Phil “Davies Decl” (P.T.A.B. Nov. 30, 2023)
Cite Document
PGR2023-00043, No. 2001 Exhibit - Expert Declaration of Stephen Graham Davies, D Phil “Davies Decl” (P.T.A.B. Nov. 30, 2023)
+ More Snippets